Bloomberg news is the first to have gotten a look at the informed consent form in the Parexel sponsored trial in the UK in which 6 subjects had adverse reactions. The consent form had major deficiencies–certaintly worthy of further inquiry by British regulatory authorities.
– Art Caplan